163 related articles for article (PubMed ID: 14681060)
1. E-cadherin binding modulates EGF receptor activation.
Fedor-Chaiken M; Hein PW; Stewart JC; Brackenbury R; Kinch MS
Cell Commun Adhes; 2003; 10(2):105-18. PubMed ID: 14681060
[TBL] [Abstract][Full Text] [Related]
2. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
[TBL] [Abstract][Full Text] [Related]
3. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
[TBL] [Abstract][Full Text] [Related]
4. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
5. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition.
Maeda M; Johnson KR; Wheelock MJ
J Cell Sci; 2005 Mar; 118(Pt 5):873-87. PubMed ID: 15713751
[TBL] [Abstract][Full Text] [Related]
6. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
Li G; Fukunaga M; Herlyn M
Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
[TBL] [Abstract][Full Text] [Related]
7. Density-dependent inhibition of growth involves prevention of EGF receptor activation by E-cadherin-mediated cell-cell adhesion.
Takahashi K; Suzuki K
Exp Cell Res; 1996 Jul; 226(1):214-22. PubMed ID: 8660958
[TBL] [Abstract][Full Text] [Related]
8. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.
Mateus AR; Seruca R; Machado JC; Keller G; Oliveira MJ; Suriano G; Luber B
Hum Mol Genet; 2007 Jul; 16(13):1639-47. PubMed ID: 17510211
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of cell adhesion and motility in living cells is altered by a single amino acid change in E-cadherin fused to enhanced green fluorescent protein.
Fuchs M; Hutzler P; Handschuh G; Hermannstädter C; Brunner I; Höfler H; Luber B
Cell Motil Cytoskeleton; 2004 Sep; 59(1):50-61. PubMed ID: 15259055
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
11. T-cadherin enhances cell-matrix adhesiveness by regulating beta1 integrin trafficking in cutaneous squamous carcinoma cells.
Mukoyama Y; Utani A; Matsui S; Zhou S; Miyachi Y; Matsuyoshi N
Genes Cells; 2007 Jun; 12(6):787-96. PubMed ID: 17573778
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of E-cadherin by an anti-epidermal growth factor receptor monoclonal antibody in lung cancer cell lines.
Al Moustafa AE; Yansouni C; Alaoui-Jamali MA; O'Connor-McCourt M
Clin Cancer Res; 1999 Mar; 5(3):681-6. PubMed ID: 10100722
[TBL] [Abstract][Full Text] [Related]
13. EGFR-dependent migration of glial cells is mediated by reorganisation of N-cadherin.
Rappl A; Piontek G; Schlegel J
J Cell Sci; 2008 Dec; 121(Pt 24):4089-97. PubMed ID: 19033391
[TBL] [Abstract][Full Text] [Related]
14. Enhanced E-cadherin expression in epidermal growth factor receptor expressing cells.
Sorscher SM; Green MR; Feramisco JR
Biochem Biophys Res Commun; 1995 Jan; 206(2):518-24. PubMed ID: 7826368
[TBL] [Abstract][Full Text] [Related]
15. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
[TBL] [Abstract][Full Text] [Related]
17. Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.
Berquin IM; Pang B; Dziubinski ML; Scott LM; Chen YQ; Nolan GP; Ethier SP
Oncogene; 2005 Apr; 24(19):3177-86. PubMed ID: 15735691
[TBL] [Abstract][Full Text] [Related]
18. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
19. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
Kuphal S; Bosserhoff AK
Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of RhoA-GTP induces activation of the Epidermal Growth Factor Receptor, dephosphorylation of focal adhesion kinase and increased motility in breast cancer cells.
Cáceres M; Guerrero J; Martínez J
Exp Cell Res; 2005 Sep; 309(1):229-38. PubMed ID: 15963982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]